Daniel A. Heller - Nanotechnology

Author Information

Daniel A. Heller is a distinguished researcher affiliated with the Memorial Sloan Kettering Cancer Center in New York, NY, United States. His work primarily focuses on the intersection of nanotechnology and biomedical applications, with a particular emphasis on cancer detection and treatment. As a researcher based at a leading cancer research institution, his contributions are significant in advancing the understanding and application of nanotechnology in medicine.

Research Contributions

Daniel A. Heller has made substantial contributions to the field of nanotechnology, particularly in the development of nanosensors and nanomaterials for biomedical applications. His recent works include the development of optical nanosensors for detecting amyloid-beta, advancements in the detection of ovarian cancer using quantum-defect-modified carbon nanotubes, and the creation of machine learning-enhanced platforms for cancer biomarker detection. His research often merges cutting-edge technologies such as hyperspectral imaging and machine learning to improve diagnostic and therapeutic methods in medicine.

Aliases

Daniel A. Heller is known by several aliases in academic publications, including D. A. Heller, Daniel A Heller, Daniel Heller, and Daniel A. Heller. These variations are common in academic circles and reflect the multiple ways his name appears in research articles.

Publication and Citation Metrics

Metric Value
Citation Count 9706
h-index 48
Paper Count 194

Publications:

DOI: 10.1101/2021.04.28.441499

Year: 2021

DOI: 10.1149/ma2021-0111562mtgabs

Year: 2021

Partnered Content Networks

Relevant Topics